NCT06805812 2025-02-03PALMARES-2Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruiting3,500 enrolled
NCT01037790 2021-03-11Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerAbramson Cancer Center at Penn MedicinePhase 2 Completed304 enrolled 12 charts